Accurately targeting chronic liver disease patients for specialty therapy
An unnamed client used HealthVerity's Audiences solution to improve patient targeting for specialty therapies treating chronic liver disease. The page states that "deeper clinical context reshapes audience accuracy for complex conditions like chronic liver disease," and frames an enhanced data foundation as enabling more precise patient identification and more efficient engagement. The landing page does not disclose specific outcomes, metrics, or numerical results -- full details are said to be in a downloadable document not accessible via this fetch.
The customer is anonymised in HealthVerity’s own case study — not withheld by us.
HealthVerity is a real-world-data marketplace aggregating claims, EHR and lab data from 75+ sources via a proprietary patient-matching layer.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by HealthVerity on its own site — read the original case study on info.healthverity.com ↗
Related use cases
- 01Symphony Health and dentsu health partner to efficiently reach rare disease patients
- 02Differentiating TYK2 inhibitors with real-world evidence in psoriasis
- 03How HealthVerity Audiences delivered 26.9x targeting precision for a rare kidney disease campaign
- 04Reducing targeting noise by supplementing claims with oncology labs: Metastatic breast cancer case study
- 05Accurately reaching patients with rare hematologic disease
- 06Accelerating early RWE exploration without increasing analytic burden